Twist Bioscience

Twist Bioscience

Life Sciences Tools & Services
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company’s proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.

$12.1B

Market Cap • 9/30/2026

2013

(13 years)

Founded

2018

(8 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

27,2

P/S

28,1

P/EBITDA

—

P/OCF

—

P/FCF

—

P/E

—

BVPS

7,1

EPS

—

Market Cap

Market Cap

12,1B

EV

12B

EV/Revenue

27,9

EV/EBITDA

-100,7

EV/EBIT

-83,1

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

-0,1%

Total Yield

-0,1%

Payout

0%

Retained Earnings

-1,4B

Profitability

Gross Margin

52%

EBITDA Margin

—

EBIT Margin

—

Net Margin

—

D&A/EBITDA

0%

R&D/Revenue

16,6%

Capex/Revenue

9,3%

Capex/D&A

157,7%

Capex/OCF

-75,5%

SBC/OCF

—

% PPE

26,9%

% Goodwill

12,2%

ROE

—

ROIC

—

Growth

CAGR Revenue 5Y

27,8%

CAGR Op. Income 5Y

1,2%

CAGR Net Income 5Y

0,2%

CAGR EPS 5Y

-4,9%

CAGR OCF 5Y

-12,4%

Leverage

N.D./EBITDA

0,6

Debt/Equity

0%

Current Ratio

2,7

Quick Ratio

1,9

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium